Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

• Vidhya Karivedu,
• Ihab Eldessouki,
• Zelia Correa,
• Ahmad Taftaf,
• Zheng Zhu,
• Abouelmagd Makramalla,
• Nagla Abdel Karim

Affiliations

Vidhya Karivedu

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Ihab Eldessouki

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Zelia Correa

Ocular Oncology Service, Department of Ophthalmology, University of Cincinnati College of Medicine, USA

Ahmad Taftaf

Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Zheng Zhu

Department of Biostatistics and Bioinformatics, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA

Abouelmagd Makramalla

Division of Vascular and Interventional Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Nagla Abdel Karim

Department of Internal Medicine, Division of Hematology/Oncology, Medical College of Georgia-Augusta University, Augusta, GA, USA